Tags: eczema | eli lilly | drug | ebglyss

FDA Approves Eli Lilly's Drug for Eczema

a person's hands with eczema
(Dreamstime)

Friday, 13 September 2024 05:00 PM EDT

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old.

The drug, branded Ebglyss, will be available in the next few weeks, the company said.

The FDA's approval was based on three studies involving over 1,000 patients with moderate-to-severe eczema who were unable to control their symptoms with topical medicines or other systemic treatments, Eli Lilly said.

Last year, the regulator had declined to approve the drug due to certain findings during an inspection of a contract manufacturer. 

© 2024 Thomson/Reuters. All rights reserved.


Health-News
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old. The drug, branded Ebglyss, will be available in the next few weeks, the company said. The FDA's approval was based on three studies...
eczema, eli lilly, drug, ebglyss
93
2024-00-13
Friday, 13 September 2024 05:00 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved